An Optical Method for Immediate Evaluation of Microfoam Stability in Foam Sclerotherapy

Skin Pharmacol Physiol. 2021;34(3):128-134. doi: 10.1159/000514322. Epub 2021 Apr 1.

Abstract

Objectives: The objective of our study was to develop an optical method that instantly evaluates the stability of sclerosing foam, which would enable early predictions of the clinical performance of the foam and reduce the occurrence of clinical side effects.

Methods: Based on the principle of light scattering, we developed a method to optically test foam stability and verified it experimentally using sodium morrhuate (2 mL; 0.05 g/mL) and carbon dioxide. A self-made foam preparation instrument was used to achieve a preparation speed of 275 mm/s. The liquid-gas ratios were considered as 1:3, 1:4, and 1:5. Curves of illuminance with respect to the drainage rate and decay time were obtained. By fitting the curve, the relationship between foam half-life time (FHT) and foam decay was obtained. Thus, foam stability was evaluated using the initial illuminance value; the foam transfer time was approximately 3 s.

Results: The experimental FHT varies between 205 and 232 s. Illuminance is exponentially related to drainage rate and linearly related with time. FHT can be expressed by the initial illuminance and illuminance curve fitting coefficients. The half-life of the foam decreases as the initial illuminance value increases, for the same sclerosing drug. The suitability of foam stability is determined by the position of the initial value in the chart.

Conclusion: Optical methods are feasible for evaluating foam stability over a short period of time. Clinically predicting the stability of freshly prepared foam can reduce number of incidences of further complications. This will promote the development of foam sclerotherapy and provide a basic understanding of the internal mechanical properties of foam.

Keywords: Foam properties; Foam stability; Instant evaluation.

MeSH terms

  • Drug Stability
  • Dynamic Light Scattering / methods*
  • Humans
  • Particle Size
  • Sclerosing Solutions / chemistry*
  • Sclerosing Solutions / therapeutic use
  • Sclerotherapy / adverse effects
  • Sclerotherapy / methods*
  • Time Factors

Substances

  • Sclerosing Solutions